Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00909480

Public ClinicalTrials.gov record NCT00909480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 10:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26 Week Randomised, Multinational, Open Labelled, 2 Armed, Parallel Group, Treat-to-target Once Daily Treatment Trial With Insulin Detemir Versus Insulin Glargine, Both in Combination With Metformin in Subjects With Type 2 Diabetes

Study identification

NCT ID
NCT00909480
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
457 participants

Conditions and interventions

Interventions

  • insulin detemir Drug
  • insulin glargine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2009
Primary completion
May 31, 2010
Completion
May 31, 2010
Last update posted
Mar 9, 2017

2009 – 2010

United States locations

U.S. sites
71
U.S. states
29
U.S. cities
66
Facility City State ZIP Site status
Novo Nordisk Investigational Site Litchfield Park Arizona 85340
Novo Nordisk Investigational Site Searcy Arkansas 72143
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Long Beach California 90822
Novo Nordisk Investigational Site Los Angeles California 90057
Novo Nordisk Investigational Site Redlands California 92374
Novo Nordisk Investigational Site Santa Ana California 92705
Novo Nordisk Investigational Site Spring Valley California 91978
Novo Nordisk Investigational Site Aurora Colorado 80045
Novo Nordisk Investigational Site Norwalk Connecticut 06851
Novo Nordisk Investigational Site Hollywood Florida 33021
Novo Nordisk Investigational Site Jacksonville Florida 32204
Novo Nordisk Investigational Site Jacksonville Florida 32207
Novo Nordisk Investigational Site Miami Florida 33136
Novo Nordisk Investigational Site Miami Florida 33143
Novo Nordisk Investigational Site Ocala Florida 34471
Novo Nordisk Investigational Site Orlando Florida 32804
Novo Nordisk Investigational Site Plantation Florida 33324
Novo Nordisk Investigational Site Ponte Vedra Florida 32081
Novo Nordisk Investigational Site Winter Haven Florida 33880
Novo Nordisk Investigational Site Powder Springs Georgia 30127
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Independence Kansas 67301-3263
Novo Nordisk Investigational Site Shawnee Mission Kansas 66204
Novo Nordisk Investigational Site Portland Maine 04101
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Waltham Massachusetts 02453
Novo Nordisk Investigational Site Buckley Michigan 49620
Novo Nordisk Investigational Site Chesterfield Missouri 63017
Novo Nordisk Investigational Site Jefferson City Missouri 65109
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site Butte Montana 59701
Novo Nordisk Investigational Site Clilfton New Jersey 07011
Novo Nordisk Investigational Site Northport New York 11768
Novo Nordisk Investigational Site Staten Island New York 10301
Novo Nordisk Investigational Site Syracuse New York 13210
Novo Nordisk Investigational Site Charlotte North Carolina 28277
Novo Nordisk Investigational Site Greensboro North Carolina 27408
Novo Nordisk Investigational Site Winston-Salem North Carolina 27103
Novo Nordisk Investigational Site Cayahoga Falls Ohio 44223
Novo Nordisk Investigational Site Cincinnati Ohio 45245
Novo Nordisk Investigational Site Dayton Ohio 45406
Novo Nordisk Investigational Site Gallipolis Ohio 45631-1560
Novo Nordisk Investigational Site Tulsa Oklahoma 74104
Novo Nordisk Investigational Site Altoona Pennsylvania 16602
Novo Nordisk Investigational Site Clarion Pennsylvania 16214
Novo Nordisk Investigational Site Lancaster Pennsylvania 17601
Novo Nordisk Investigational Site Norristown Pennsylvania 19401
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19104
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Spartanburg South Carolina 29303
Novo Nordisk Investigational Site Taylors South Carolina 29687
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Corpus Christi Texas 78404
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Houston Texas 77025
Novo Nordisk Investigational Site Hurst Texas 76054
Novo Nordisk Investigational Site Odessa Texas 79761
Novo Nordisk Investigational Site San Antonio Texas 78209
Novo Nordisk Investigational Site St. George Utah 84790
Novo Nordisk Investigational Site Virginia Beach Virginia 23462
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Martinsburg West Virginia 25401
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00909480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2017 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00909480 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →